Literature DB >> 15951445

The use of calnexin and calreticulin by cellular and viral glycoproteins.

Michel Pieren1, Carmela Galli, Angela Denzel, Maurizio Molinari.   

Abstract

Calnexin and calreticulin are homologous lectin chaperones that assist maturation of cellular and viral glycoproteins in the mammalian endoplasmic reticulum. Calnexin and calreticulin share the same specificity for monoglucosylated protein-bound N-glycans but associate with a distinct set of newly synthesized polypeptides. We report here that most calnexin substrates do not associate with calreticulin even upon selective calnexin inactivation, while BiP associates more abundantly with nascent polypeptides under these conditions. Calreticulin associated more abundantly with orphan calnexin substrates only in infected cells and preferentially with polypeptides of viral origin, showing stronger dependence of model viral glycoproteins on endoplasmic reticulum lectins. This may explain why inactivation of the calnexin cycle affects viral replication and infectivity but not viability of mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951445     DOI: 10.1074/jbc.M501020200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?

Authors:  Martin McLaughlin; Koen Vandenbroeck
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 2.  Getting in and out from calnexin/calreticulin cycles.

Authors:  Julio J Caramelo; Armando J Parodi
Journal:  J Biol Chem       Date:  2008-02-26       Impact factor: 5.157

Review 3.  N-linked glycan recognition and processing: the molecular basis of endoplasmic reticulum quality control.

Authors:  Kelley W Moremen; Maurizio Molinari
Journal:  Curr Opin Struct Biol       Date:  2006-08-30       Impact factor: 6.809

4.  Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals.

Authors:  Alessandro T Caputo; Dominic S Alonzi; Lucia Marti; Ida-Barbara Reca; J L Kiappes; Weston B Struwe; Alice Cross; Souradeep Basu; Edward D Lowe; Benoit Darlot; Angelo Santino; Pietro Roversi; Nicole Zitzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-26       Impact factor: 11.205

5.  Human Herpesvirus 8 Interleukin-6 Interacts with Calnexin Cycle Components and Promotes Protein Folding.

Authors:  Daming Chen; Qiwang Xiang; John Nicholas
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 6.  How sugars convey information on protein conformation in the endoplasmic reticulum.

Authors:  Julio J Caramelo; Armando J Parodi
Journal:  Semin Cell Dev Biol       Date:  2007-09-08       Impact factor: 7.727

7.  ER-to-lysosome-associated degradation of proteasome-resistant ATZ polymers occurs via receptor-mediated vesicular transport.

Authors:  Ilaria Fregno; Elisa Fasana; Timothy J Bergmann; Andrea Raimondi; Marisa Loi; Tatiana Soldà; Carmela Galli; Rocco D'Antuono; Diego Morone; Alberto Danieli; Paolo Paganetti; Eelco van Anken; Maurizio Molinari
Journal:  EMBO J       Date:  2018-08-03       Impact factor: 11.598

8.  Calcium as a crucial cofactor for low density lipoprotein receptor folding in the endoplasmic reticulum.

Authors:  Florentina Pena; Annemieke Jansens; Guus van Zadelhoff; Ineke Braakman
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

9.  Suppressive roles of calreticulin in prostate cancer growth and metastasis.

Authors:  Mahesh Alur; Minh M Nguyen; Scott E Eggener; Feng Jiang; Soheil S Dadras; Jeffrey Stern; Simon Kimm; Kim Roehl; James Kozlowski; Michael Pins; Marek Michalak; Rajiv Dhir; Zhou Wang
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

Review 10.  Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Authors:  Bruno Di Jeso; Peter Arvan
Journal:  Endocr Rev       Date:  2015-11-23       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.